DESCRIPTION OF BUSINESS - License and Distribution Agreements (Cleave Therapeutics, Inc.) (Details) - USD ($) $ in Millions |
12 Months Ended | |
|---|---|---|
Jul. 18, 2023 |
Dec. 31, 2021 |
|
| Assignment Agreement with Cleave | ||
| Description of Business and Basis of Presentation | ||
| Principal amount | $ 5.5 | $ 1.0 |
| Assignment agreement, percentage of royalty on net sales payable | 2.50% | |
| Assignment Agreement with Cleave | Maximum | ||
| Description of Business and Basis of Presentation | ||
| Assignment agreement, commercial and sales milestone payments payable | $ 66.0 | |
| Cleave Therapeutics, Inc | ||
| Description of Business and Basis of Presentation | ||
| Upfront payment | 5.5 | |
| Acquired in-process research and development | 5.5 | |
| Principal amount | $ 1.0 | |
| Cleave Therapeutics, Inc | Maximum | ||
| Description of Business and Basis of Presentation | ||
| Milestone payment | $ 74.0 |